NO20055616L - Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet - Google Patents

Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet

Info

Publication number
NO20055616L
NO20055616L NO20055616A NO20055616A NO20055616L NO 20055616 L NO20055616 L NO 20055616L NO 20055616 A NO20055616 A NO 20055616A NO 20055616 A NO20055616 A NO 20055616A NO 20055616 L NO20055616 L NO 20055616L
Authority
NO
Norway
Prior art keywords
drug
agent
antimicrobial
formulation
against organisms
Prior art date
Application number
NO20055616A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055616D0 (no
Inventor
James E Kipp
Joseph Chung Tak Wong
Mark J Doty
Christine L Rebbeck
Chong-Son Sun
Pavlos Papadopoulos
Barrett E Rabinow
Randy White
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO20055616D0 publication Critical patent/NO20055616D0/no
Publication of NO20055616L publication Critical patent/NO20055616L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20055616A 2003-04-29 2005-11-28 Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet NO20055616L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46635403P 2003-04-29 2003-04-29
PCT/US2004/013268 WO2004096180A1 (fr) 2003-04-29 2004-04-29 Formulation destinee a rendre un medicament antimicrobien efficace contre des organismes normalement consideres comme etant resistant a ce medicament

Publications (2)

Publication Number Publication Date
NO20055616D0 NO20055616D0 (no) 2005-11-28
NO20055616L true NO20055616L (no) 2006-01-25

Family

ID=33418369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055616A NO20055616L (no) 2003-04-29 2005-11-28 Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet

Country Status (11)

Country Link
EP (1) EP1617818A1 (fr)
JP (1) JP2006525345A (fr)
KR (1) KR20060015553A (fr)
CN (1) CN1794975A (fr)
AU (1) AU2004234003A1 (fr)
BR (1) BRPI0409929A (fr)
CA (1) CA2523151A1 (fr)
MX (1) MXPA05011607A (fr)
NO (1) NO20055616L (fr)
WO (1) WO2004096180A1 (fr)
ZA (1) ZA200508467B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858508B1 (ko) 2005-12-23 2008-09-12 주식회사 삼양사 아졸계 항진균제를 포함하는 조성물 및 그의 제조방법
KR20090015994A (ko) * 2006-05-30 2009-02-12 엘란 파마 인터내셔널 리미티드 나노입자형 포사코나졸 제제
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
ES2476240T3 (es) * 2010-12-30 2018-03-06 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" Agente antibacteriano para el tratamiento de enfermedades infecciosas de origen bacteriano
CN102085176A (zh) * 2010-12-31 2011-06-08 江苏中丹制药有限公司 一种纳米级伊曲康唑外用制剂、其制备方法及其用途
CN102106832A (zh) * 2011-02-12 2011-06-29 华中师范大学 酮康唑纳米混悬剂冻干粉及其制备方法
JP6962655B2 (ja) * 2015-07-07 2021-11-05 ライフラフト バイオサイエンシーズ，インコーポレイテッド 低ナトリウムポロキサマー１８８製剤および使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1079808B1 (fr) * 1998-05-29 2004-02-11 Skyepharma Canada Inc. Compositions de microparticules a protection thermique et procede de sterilisation a la vapeur apres conditionnement
KR100801588B1 (ko) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 생물학적 유효 물질의 표면 변형된 미립자 조성물
WO2002055059A2 (fr) * 2000-12-22 2002-07-18 Baxter Int Preparation de suspensions de particules submicroniques
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix

Also Published As

Publication number Publication date
CA2523151A1 (fr) 2004-11-11
AU2004234003A1 (en) 2004-11-11
JP2006525345A (ja) 2006-11-09
NO20055616D0 (no) 2005-11-28
ZA200508467B (en) 2006-09-27
EP1617818A1 (fr) 2006-01-25
WO2004096180A1 (fr) 2004-11-11
BRPI0409929A (pt) 2006-04-25
KR20060015553A (ko) 2006-02-17
CN1794975A (zh) 2006-06-28
MXPA05011607A (es) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20055616L (no) Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet
NO20073559L (no) Nanopartiklulaere tacrolimus-formuleringer
TN2009000210A1 (en) Liquid formulation of carboxamide arthropodicides
IL145767A0 (en) Microbicidal formulation comprising an essential oil or their derivatives
DE602006016125D1 (de) Dispergiermittel und zusammensetzungen davon
DK1471887T3 (da) Nanopartikelkompositioner der har lysozym som overfladestabiliseringsmiddel
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
DE602005025083D1 (fr)
WO2003045344A3 (fr) Compositions de dentifrice comprenant une phase stable faible en eau composee de polyphosphate et d'elements ioniques actifs
WO2005002542A3 (fr) Formulations de meloxicane nanoparticulaires
DE502005006879D1 (de) Wasserbasis
HUP0302021A2 (hu) Szteroid tartalmú stabilizált vizes szuszpenziók parenterális használathoz
ATE399847T1 (de) Reinigungsmittel vom typ der multiplen emulsion
BR0317554A (pt) Compostos peroxigenados revestidos com liberação controlada, um processo para preparação deles e uso dos mesmos
HK1120794A1 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
JP2006282629A (ja) スプレー用組成物
DE60326263D1 (de) Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten
RU2007138389A (ru) Паразитицидная водная суспензия
JP2011520796A (ja) マイクロエマルション殺菌組成物
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
MY151115A (en) Disinfectant and/or bactericidal aqueous compositions
DE602006001731D1 (de) Verwendung von pyrimidinetrion-derivaten als acetylcholinesterase-hemmer, diese enthaltende zusammensetzungen und deren verwendungen
GB0100643D0 (en) Liquid antimicrobial compositions
AU2003286210A1 (en) Smoke composition
PL1622447T3 (pl) Wodna, płynna kompozycja koncentratu pendimetaliny

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application